Growth Hormone
Ipamorelin
Synthetic pentapeptide and selective growth-hormone secretagogue (GHS) used in laboratory settings to study GH-related signaling via the GHS-R1a receptor. Unlike broader GHRPs, Ipamorelin is examined for its ability to stimulate GH release with minimal activity at receptors influencing ACTH, cortisol, prolactin, FSH, LH, or TSH in preclinical models. Half-life of ~2 hours and time to peak GH release of ~0.67 hours in preclinical studies. Activates cAMP/PKA signaling, supporting pulsatile GH-release patterns observed in experimental settings.
Research Areas
- Selective GH signaling
- Pulsatile GH dynamics
- Injection-interval modeling
- GH-linked repair models
- Myogenic and metabolic signaling
- Sleep-architecture research
Sold exclusively to licensed medical and clinical B2B accounts. Intended for professional use under the supervision of licensed practitioners.